Overview

Dexmedetomidine As an Adjuvant to Bupivacaine in Bilateral PECs for Pain Control After Cardiac Surgeries

Status:
RECRUITING
Trial end date:
2025-05-01
Target enrollment:
Participant gender:
Summary
the study aims to test the quality of analgesia provided by dexmedetomidine as an adjuvant to bupivacaine bilateral PECs block in patients scheduled for cardiothoracic surgeries with median sternotomy incision.
Phase:
PHASE4
Details
Lead Sponsor:
Kasr El Aini Hospital
Treatments:
Dexmedetomidine